BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02411656-completion@plaintrial.com
DTSTAMP:20261027T033247Z
DTSTART;VALUE=DATE:20281231
SUMMARY:Pembrolizumab in Treating Patients With Stage IV Metastatic or Recu
 rrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have
  Achieved Clinical Response or Stable Disease to Prior Chemotherapy — es
 timated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02411656
URL:https://plaintrial.com/trial/NCT02411656
END:VEVENT
END:VCALENDAR
